Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical AcQMap High Resolution Imaging and Mapping System. The goal of the collaboration is to improve patient care and the physician experience in electrophysiology.

In March, I made a day trip to New York City to receive the 2017 Jesse H. Neal Award for Best Use of Social Media. The award was in recognition of DAIC’s extensive use of social media in 2017, which helped the magazine set a record with 1.4 million website pageviews in 2017.

Balancing high quality care with efficiency — and avoiding unnecessary procedures — is a priority for any hospital department given the continuing need to manage increasing demand for services with budgetary pressure.

An 3D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.
Edwards Lifesciences puchased Valtech to acquire the CardioBand transcatheter annuloplasty system technology. It received market clearance in Europe in April 2018.

May 4, 2018 — Transcatheter valve technology has been advancing very quickly and the links to aggregated content from the past year below offer a concise update. Transcatheter aortic valve replacement (TAVR) use has greatly expanded over the past several years. The Boston Scientific Lotus TAVR valve is now positioned to most likely become the third TAVR device available on the U.S. market in the next 18 months.

May 3, 2018 — The U.S. Food and Drug Administration (FDA) recently announced the availability of a draft guidance for industry entitled, “Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials.”

EuroSciCon Congress on Heart Disease and Interventional Cardiology

May 3, 2018 — APN Health LLC announced its Navik 3D mapping system is commercially released and in clinical use. The first clinical case using the technology was performed on March 22 at St. Luke’s Medical Center in Milwaukee.

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has granted market clearance for the Abbott Advisor HD Grid Mapping Catheter, Sensor Enabled. The new electrophysiology (EP) mapping catheter design allows physicians to see things differently during transcatheter EP cardiac ablation procedures. This includes capturing and analyzing data in a novel manner to create highly detailed maps of the heart that better differentiate healthy from unhealthy tissue. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now